GlassScriptPhysician profile
Christopher Anthony Rhea
NPI 1679876809
$2,031.30
in general payments reported to CMS, 2019-2025
11 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $353 · 2021: $143 · 2022: $267 · 2023: $136 · 2024: $276 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $593.31 | 2022-2025 | Infuse, Biotrue One Day |
| Johnson & Johnson Vision Care, INC. | $371.47 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $275.13 | 2019-2024 | Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $253.52 | 2019-2021 | |
| Optos, INC. | $160.48 | 2019-2020 | |
| Dompe US, INC. | $118.73 | 2024 | Oxervate |
| Coopervision INC. | $94.86 | 2020 | |
| Abb Con-Cise Optical Group LLC | $57.88 | 2019-2023 | Contact Lens, Spectacle Lenses |
| Integra Lifesciences Corporation | $53.60 | 2019 | |
| Sight Sciences, INC. | $32.92 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rhea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.